+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Endotoxin Testing Market by Offering (Instruments, Reagents & Kits, Software), Test Type (Chromogenic Tests, Gel Clot Tests, Limulus Amebocyte Lysate Test), Application, End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977667
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endotoxin Testing Market grew from USD 1.22 billion in 2023 to USD 1.33 billion in 2024. It is expected to continue growing at a CAGR of 9.47%, reaching USD 2.30 billion by 2030.

This type of testing specifically looks for endotoxins, which are toxic substances found in the outer membrane of certain bacteria called Gram-negative bacteria. The testing primarily involves methods that can detect even small amounts of endotoxins and is a standard procedure during the manufacturing process of medical products. The demand for endotoxin testing is significantly driven by the rising prevalence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases, which necessitate the development of biopharmaceuticals. Endotoxin testing ensures the safety and efficacy of these medications, making it a critical component in the pharmaceutical industry. However, strict regulations and the lack of standardization in endotoxin testing protocols can hinder market growth. Inconsistencies in testing procedures and standards may lead to uncertainties and variabilities in test results, affecting product safety and efficacy assessments. Moreover, the development of enhanced Limulus Amebocyte Lysate (LAL) assays for endotoxin testing is a significant factor that presents a significant opportunity for companies and end users. Improved sensitivity and faster turnaround times in these assays allow for more efficient monitoring of bacterial contamination in pharmaceuticals and other products, ensuring compliance with safety standards.

Regional Insights

In the Americas, particularly the United States and Canada, the endotoxin testing market is mature, with a robust framework for regulations and compliance driving the demand. The United States has led the adoption of innovative endotoxin testing technologies, largely due to the presence of major pharmaceutical companies and cutting-edge research institutions. Canada, sharing close regulatory and economic ties with the U.S., follows similar trends and demonstrates stringent enforcement of safety standards, which sustains the demand for quality endotoxin testing. In Europe, the emphasis is on harmonizing safety standards across member states under the European Medicines Agency (EMA) guiding framework. Investment in new drug development and a high standard of public health policies drive the need for reliable endotoxin testing procedures. Also, recent research initiatives focus on enhancing the sensitivity and specificity of existing testing methodologies. Moreover, the Asia Pacific region exhibits significant growth in the endotoxin testing market, primarily driven by rapidly expanding pharmaceutical and biotechnology sectors in countries including China, India, and Japan. Consumer needs in this area focus on ensuring high patient safety standards and complying with international and local regulatory guidelines for pharmaceutical products and medical devices. There has been a surge in the establishment of biopharmaceutical manufacturing plants in the region, fueled by the government's support through funding and initiatives to localize the production of critical healthcare products. Recent patents in the region reflect advancements in methods and equipment designed to provide more accurate, efficient, and cost-effective endotoxin testing.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Endotoxin Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of chronic illnesses across the globe
  • Surge in biologics and generics production due to their cost-effectiveness
  • Integration of endotoxin testing across different stages of drug development

Market Restraints

  • High costs associated with endotoxin testing procedures

Market Opportunities

  • Advancements in Limulus Amebocyte Lysate technology
  • Government mandates for use of endotoxin testing across stages of pharmaceutical production

Market Challenges

  • Variability in test results of endotoxin testing solutions

Market Segmentation Analysis

  • Offering: Utilization of LAL test cartridges and systems in endotoxin testing to ensure the accuracy and regulatory compliance
  • Application: Increasing usage of endotoxin testing to ensure the safety and efficacy of medical and pharmaceutical products in clinical settings

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Endotoxin Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Endotoxin Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Enhanced Precision in Biopharmaceutical Endotoxin Testing Through Strategic Collaboration

FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Inc. have entered a strategic collaboration to advance the accuracy of bacterial endotoxin testing in biopharmaceuticals. This collaboration combines Predictive Oncology’s EndoPrep technology with FUJIFILM’s PYROSTAR detection reagent. Together, these technologies aim to improve the detection of residual endotoxins by effectively eliminating protein interference in the testing process. This initiative marks a significant step towards enhancing the safety and reliability of biopharmaceutical products.

Charles River Launches Innovative Animal-Free Rapid Endotoxin Testing Solution

Charles River has unveiled the Endosafe Trillium, a rapid bacterial endotoxin test that employs recombinant cascade reagent (rCR) cartridges. This innovative product is designed to enhance testing efficiency and support sustainability and animal welfare practices by eliminating the need for animal-derived components. The Endosafe Trillium addresses both environmental concerns and the demand for ethical scientific methodologies, marking a significant advancement in the field of bacteriological testing.

Lonza Introduces the Nebula Absorbance Reader for Enhanced Endotoxin Detection

Lonza expanded its product offerings by introducing the Nebula Absorbance Reader, a cutting-edge absorbance microplate reader designed to enhance the efficiency of endotoxin and pyrogen testing in pharmaceutical quality control labs. This new instrument is set to join an array of specialized tools that currently aid in conducting traditional Limulus amebocyte lysate (LAL) and Tachypleus amebocyte lysate (TAL) assays. These assays are essential for ensuring the safety of pharmaceutical raw materials, in-process samples, and final products by detecting harmful bacterial endotoxins.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Endotoxin Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Endotoxin Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Agilent Technologies, Inc., ARL Bio Pharma, Associates of Cape Cod, Inc., Bio-Rad Laboratories, Inc., Bio-Synthesis Inc., BioMérieux SA, Charles River Laboratories International, Inc., Eurofins Scientific SE, Fujifilm Corporation, GenScript Biotech Corporation, Labcorp, Lonza Group Ltd., Merck KGaA, METTLER TOLEDO, Nelson Laboratories, LLC by Sotera Health Company, Pace Analytical Services, LLC, Pacific BioLabs, QIAGEN N.V., SGS SA, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Endotoxin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering

  • Instruments
  • Reagents & Kits
  • Software

Test Type

  • Chromogenic Tests
  • Gel Clot Tests
  • Limulus Amebocyte Lysate Test
  • Turbidimetric Tests

Application

  • Clinical Testing
  • Medical Device Testing
  • Pharmaceutical & Biotechnology Testing

End-Use

  • Contract Research Organizations
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic illnesses across the globe
5.1.1.2. Surge in biologics and generics production due to their cost-effectiveness
5.1.1.3. Integration of endotoxin testing across different stages of drug development
5.1.2. Restraints
5.1.2.1. High costs associated with endotoxin testing procedures
5.1.3. Opportunities
5.1.3.1. Advancements in Limulus Amebocyte Lysate technology
5.1.3.2. Government mandates for use of endotoxin testing across stages of pharmaceutical production
5.1.4. Challenges
5.1.4.1. Variability in test results of endotoxin testing solutions
5.2. Market Segmentation Analysis
5.2.1. Offering: Utilization of LAL test cartridges and systems in endotoxin testing to ensure the accuracy and regulatory compliance
5.2.2. Application: Increasing usage of endotoxin testing to ensure the safety and efficacy of medical and pharmaceutical products in clinical settings
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Endotoxin Testing Market, by Offering
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
6.4. Software
7. Endotoxin Testing Market, by Test Type
7.1. Introduction
7.2. Chromogenic Tests
7.3. Gel Clot Tests
7.4. Limulus Amebocyte Lysate Test
7.5. Turbidimetric Tests
8. Endotoxin Testing Market, by Application
8.1. Introduction
8.2. Clinical Testing
8.3. Medical Device Testing
8.4. Pharmaceutical & Biotechnology Testing
9. Endotoxin Testing Market, by End-Use
9.1. Introduction
9.2. Contract Research Organizations
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical & Biotechnology Companies
9.5. Research & Academic Institutes
10. Americas Endotoxin Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Endotoxin Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Endotoxin Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Enhanced Precision in Biopharmaceutical Endotoxin Testing Through Strategic Collaboration
13.3.2. Charles River Launches Innovative Animal-Free Rapid Endotoxin Testing Solution
13.3.3. Lonza Introduces the Nebula Absorbance Reader for Enhanced Endotoxin Detection
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ENDOTOXIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. ENDOTOXIN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENDOTOXIN TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ENDOTOXIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ENDOTOXIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENDOTOXIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ENDOTOXIN TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. CANADA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 70. CANADA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 71. CANADA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. CANADA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. CANADA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. CANADA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 78. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 79. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 80. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 81. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. MEXICO ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES ENDOTOXIN TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 113. CHINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 114. CHINA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 115. CHINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 116. CHINA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 117. CHINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. CHINA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. CHINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. CHINA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. INDIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 122. INDIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 123. INDIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. INDIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. INDIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 128. INDIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 137. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 138. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 139. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 140. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 141. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. JAPAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 185. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 186. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 187. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 188. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 189. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. THAILAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 211. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 212. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 213. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 214. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 215. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. DENMARK ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 220. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 221. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 222. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 223. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. EGYPT ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 228. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 229. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 230. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 231. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. FINLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 236. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 237. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 238. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 239. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. FRANCE ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 244. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 245. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 246. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 247. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. GERMANY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 259. ITALY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 260. ITALY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 261. ITALY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 262. ITALY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 263. ITALY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. ITALY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. ITALY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. ITALY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 284. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 285. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 286. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 287. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 290. NORWAY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 291. POLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 292. POLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 293. POLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 294. POLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 295. POLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. POLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. POLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 298. POLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 299. QATAR ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 300. QATAR ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 301. QATAR ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 302. QATAR ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 303. QATAR ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 304. QATAR ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305. QATAR ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 306. QATAR ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 331. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 332. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 333. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 334. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 335. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 336. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 337. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 338. SPAIN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 355. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 356. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 357. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 358. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 359. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 360. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 361. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 362. TURKEY ENDOTOXIN TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES ENDOTOXIN TESTING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES ENDO

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accugen Laboratories, Inc.
  • Agilent Technologies, Inc.
  • ARL Bio Pharma
  • Associates of Cape Cod, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Synthesis Inc.
  • BioMérieux SA
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Fujifilm Corporation
  • GenScript Biotech Corporation
  • Labcorp
  • Lonza Group Ltd.
  • Merck KGaA
  • METTLER TOLEDO
  • Nelson Laboratories, LLC by Sotera Health Company
  • Pace Analytical Services, LLC
  • Pacific BioLabs
  • QIAGEN N.V.
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information